StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.48−0.08 (-5.13%)

Close on Nov 17, 2026Market cap $526.23MP/E –Yield –

Evotec gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 14.5%, against 14.4% the year before. The highest annual figure on record is 29.8% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202514.5%+0.1
FY2024Dec 31, 202414.4%−8.0
FY2023Dec 31, 202322.4%−0.8
FY2022Dec 31, 202223.2%−1.4
FY2021Dec 31, 202124.5%−0.6
FY2020Dec 31, 202025.1%−4.7
FY2019Dec 31, 201929.8%–

More Evotec figures

See a number that looks wrong?